micronucleated RETs are indicative of recent damage, whereas micronucleated NCEs are indicative of damage caused >72 h earlier. RETs can be distinguished from NCEs by studying the expression of the mouse transferrin receptor (CD71), which is present on the surface of most dividing hematopoietic progenitor cells 28 . In 1996, Dertinger et al. 29 refined the method using a fluorescein-conjugated monoclonal antibody to the CD71 receptor, which labels the RET population. The use of PI to stain DNA (after removal of RNA from RETs by incubation with RNase) simplified the assay by enabling the use of a single-laser flow cytometer for enumeration of cells (patent nos. US6100038A and US5858667A; ref. 30) .
In 2003, Shima et al. used the assay developed by Dertinger et al. 29 to genetically screen mice for novel genes required for vertebrate genome maintenance 31, 32 . Here we have scaled down Dertinger's method to perform the assay in 96-well plates (Fig. 2) , which we have used to assess genome stability in >10,000 mice as part of a large-scale reverse genetic screen in association with the Mouse Genetics Project at the Wellcome Trust Sanger Institute 33 . The program screens genetically modified mice as part of an international effort to associate gene function with developmental abnormalities and disease. By combining the assay with high-throughput phenotyping of mice, we have identified several novel mouse models of rare genome-instability disorders, novel genome-maintenance-related genes, including Cenpj and Mysm1, and cancer predisposition-related genes including Slx4 (refs. 11,34-38) . If such a screen were to be performed for the human population, albeit with a slightly modified method that enriches for RETs before assay processing owing to the efficient clearance of micronucleated erythrocytes by the human spleen 39 , the assay could aid the diagnosis of novel genome instability syndromes or identify individuals who may be predisposed to cancer owing to elevated basal levels of genome instability. Furthermore, by incorporating a challenge with ionizing radiation into the mouse phenotyping pipeline, we have identified radiationsensitive mutants, which exhibit increased levels of micronucleated RETs after irradiation but not before irradiation. Here we provide additional details on data analysis, troubleshooting and potential sources of data variability and false-positive increases in numbers of micronucleated red blood cells.
Our high-throughput flow cytometric micronucleus assay is relatively quick, inexpensive and simple to perform. It uses equipment that is available in most research organizations, and it is reliable if performed according to the instructions provided herein. It therefore makes an ideal test for the detection of genome instability in vivo that is minimally invasive and does not require the death of the animal, meaning that it can easily be incorporated into a phenotyping screen. We provide step-by-step technical advice, as well as a troubleshooting guide with tips gleaned from our use of the method over the past few years.
Figure 1 | Micronucleus induction during erythropoiesis. (a)
Erythropoiesis is characterized by maturation of the multipotent hematopoietic stem cell (not shown) to a smaller, mitotically inactive normoblast. Within the normoblast, chromatin begins to condense, and eventually the pyknotic nucleus is expelled, yielding a cell that is known as a reticulocyte (RET). The RETs migrate from the bone marrow to the peripheral circulation, where, 1 or 2 d later, it matures into an NCE, which is characterized by degradation of the reticular RNA mesh and loss of transferrin receptor (CD71) expression. Micronuclei can form spontaneously during the mitotic stages of erythropoiesis-for example, within the multipotent hematopoietic stem cell or differentiated precursor cells (normoblasts); however, in normal cells this is an extremely rare event. Although the nucleus is expelled during red blood cell maturation, the micronucleus is retained. If cells are genomically unstable or mice have been treated with a genotoxin, the frequency of micronucleus formation increases. Micronuclei are PI positive, and they can be differentially identified in NCEs or RETs by co-staining with CD71.
(b) May-Grünwald-Giemsa staining of fresh blood sample from a wild-type mouse shows a Giemsa-positive DNA fragment (micronucleus) in an erythrocyte. (c,d) DAPI-stained micronucleated erythrocyte from a blood sample prepared according to the methods indicated in this protocol (heparin anticoagulation followed by fixation in −80 °C methanol). The methanol-fixed blood was cytospun onto a slide and DAPI-stained (c shows staining with overlay phase-contrast/DAPI, whereas d shows staining with DAPI alone 
Limitations of the method
The high-throughput micronucleus assay gives an indication of genome stability as measured by the frequency of micronucleated erythrocytes in a population. The assay does not provide information on the structure of the micronucleus, and therefore it does not distinguish between the different mechanisms of action of inducers, such as clastogens or aneugens, nor does the assay inform on whether a cell has a single micronucleus or multiple micronuclei, as could be determined by conventional microscopy. Therefore, further experiments are needed to determine the structure of the micronucleus and mechanism of its formation. For example, we have previously shown that fibroblasts derived from Cenpj-deficient mice (1.5-fold increase in the percentage of micronucleated NCEs) are prone to tetraploidy, as shown by multiplex metaphase fluorescent in situ hybridization and indicated by cell cycle analysis 35 . This suggested that micronuclei were likely
Box 1 | Sources of variation in micronucleus frequency
Below we highlight significant sources of variation in micronucleus frequency that should be taken into consideration during experimental design.
sex
For all mouse strains that we have tested, the frequency of micronucleated NCEs for male mice was significantly increased when compared with female mice. For example, female C57BL/6N mice have a mean of 0.14% micronucleated NCEs, whereas the mean for male mice is 0.21% (P = 0.0002, mixed model analysis where sex is a fixed effect and assay date is a random effect; Fig. 3a ).
Genetic background
The assay is sensitive enough to detect significant differences between inbred strains of mice (Fig. 3b) . Compared with 129SvEv mice (n = 27), C57BL/6JIco mice (n = 15) have a higher basal level of % micronucleated NCEs (0.186% compared with 0.143%; P = 0.002; mixed model analysis for which core strain is a fixed effect and assay date is a random effect). Relative to the variance of 129SvEv (i.e., variance of 1), the variance of C57BL/6JIco is similar (relative variance = 1.18), whereas the variance of mixed strains is more than three times greater (relative variance of B6Brd;129S5-Tyr c-Brd = 3.29, CBACa;129S5 = 3.63; P = 0.0065 mixed model analysis, Fig. 3b ), demonstrating that data variability is greater for mice with mixed genetic backgrounds than for those with pure genetic backgrounds. This finding should be considered when determining statistical power. It should be noted that when comparing mixed genetic backgrounds comprising substrains of laboratory mice the variance is low (Fig. 3b) . For example, if we compare the variance of a mixed strain of mice, where all strains are historically derived from BL/6 mice, then the variance is similar to that of a pure inbred strain (variance of B6Brd;B6Dnk;B6N-Tyr c-Brd = 0.92 relative to the pure, inbred strain 129SvEv). In summary, assay sensitivity is highest when mice are of the same sex and are bred on a pure genetic background (Fig. 3c) . age DNA damage is thought to accumulate with age, and therefore older mice may have higher frequencies of spontaneous micronucleus formation than young mice 45 . We recommend that mice be age-matched when possible.
assay date
By performing the micronucleus assay as part of a large-scale phenotyping pipeline, we have found that, as with other phenotyping variables, assay date is a major source of variation 46 . The variation with date arises from multiple factors including researcher, reagent lot, cage, and mother and litter size. This temporal variation has a significant impact on data analysis, as readings taken on the same day are more similar than readings on different days. The simplest approach to manage this source of variation is to process all samples at the same time, which will enable the use of standard statistical methods such as the Student's t-test. When it is not possible to collect samples and process them on the same day, such as with a large-scale phenotyping pipeline, micronucleus data can be analyzed with a mixed model approach, in which genotype is treated as a fixed effect and assay date is treated as a random effect. This separates the genotype effect from the temporal variation by assuming that temporal variation is normally distributed with a mean of zero and with a defined variance. We refer the reader to Karp et al. 46 for further statistical design considerations with regard to assay date.
statistical power
Data from 200 blood samples obtained from male C57BL/6N wild-type mice, which were screened over seven assay dates, were used to determine the appropriate statistical method and associated statistical power. Across the seven data sets, the percentage of micronucleated NCE data were normally distributed, as assessed by graphical inspection (normal Q-Q plot) and Shapiro-Wilk normality test (data not shown). These data characteristics indicate that a standard Student's t-test is appropriate to detect changes in the mean percentage of micronucleated NCEs between the control group and the test group, subject to the experimental design implemented. The average s.d. was estimated to be 0.026%. By using the variance estimate, we assessed the power to detect changes of ±0.05%, 0.1% and 0.2% micronucleated NCEs for different samples sizes when using a two-tailed, two-sample Student's t-test 47 . For hypothesis testing of age-, sex-and genetic backgroundmatched test and control mice, we recommend a target power of >0.8. For confirmation of genomic instability mutants, we suggest a power ≥ 0.95 (Fig. 3d) . The power calculations showed that the assay is very sensitive and that n = 3 mice per genotype is enough to test for differences >0.1% micronucleated NCEs (~1.5-fold change for C57BL/6N mice) in a confirmation experiment, and that n = 6 mice per genotype are required to test differences as low as 0.05% micronucleated NCEs (~1.25-fold change for C57BL/6N mice) in a screening experiment. The variance of mixed genetic backgrounds is greater than for pure genetic backgrounds, and this will reduce the statistical power (Fig. 3b) .
to be the result of chromosome mis-segregation; fluorescence microscopy revealed that fibroblasts had an increased frequency of supernumerary centrosomes and multipolar spindles, which have been shown to cause aneuploidy 35 .
Alternatively, micronuclei can also be detected in vitro using the cytokinesis block micronucleus cytome assay 40 . In addition to quantifying micronuclei, the cytokinesis block micronucleus cytome assay also detects cytostasis, cytotoxicity and provides information on the structure of the micronucleus. This added information is useful for determining the likely mechanism of micronucleus formation. For example, nucleoplasmic bridges are a biomarker of misrepair and/or telomere end fusions, whereas nuclear buds are a biomarker of elimination of amplified DNA and/or DNA repair complexes 40 . However, the cytokinesis block micronucleus cytome assay is time-consuming, and it relies on a complicated scoring system. In summary, the high-throughput micronucleus assay is a fast and sensitive method for the detection of micronuclei, but further experiments are needed to ascertain the mechanism of its formation.
Through screening for micronucleus induction in parallel with a large-scale, unbiased mouse phenotyping pipeline, we have identified several factors that may influence the detection of true, micronucleated red blood cells with the assay. Regenerative anemia causes increased production of red blood cells DNA damage response (DDR) defects can be revealed by treating mice that show normal spontaneous micronucleus frequencies with genotoxic agents. Upon treatment, micronuclei form in mitotically dividing erythroid progenitor cells, and they can be detected 24-72 h later in peripheral RETs ( Fig. 1 and Fig. 4a,b) . This procedure can be used to create positive control samples from wild-type control animals or for the identification of deficiencies that are only apparent, or amplified, in response to DDR challenge. This enables the researcher to detect genes that are not necessary for the response to endogenous DDR stress, such that their deregulation does not produce elevated spontaneous micronucleus levels, but which are crucial for the response to DNA damage. 
antIcIpateD results
Wild-type mice treated with these genotoxins show a significant increase in the percentage of micronucleated RETs 24 and 48 h after treatment, and recovery is observed 72 h after treatment (Fig. 4a,b) . For example, 48 h after 0.75 Gy, wild-type mice have a mean fivefold increase in the percentage of micronucleated RETs (baseline mean = 0.61% for n = 10; 48 h after 0.75 Gy mean = 3.05% for n = 3), whereas 48 h after administration of 1 mg/kg MMC wild-type mice have a sevenfold increase (baseline mean = 0.61% for n = 10; 48 h after treatment mean = 4.23% for n = 3). Genotoxin sensitivity is characterized by a normal percentage of micronucleated RET frequency before treatment, but a marked increase in the percentage of micronucleated RETs versus control, 48 h after treatment. (reticulocytosis) and activation of extramedullary hematopoiesis 41 . In extreme cases of reticulocytosis, such as that observed in 16-20-week-old C57BL/6J Apc min/+ mice ( Supplementary  Fig. 1a,b) , the main nucleus may not be expelled during erythropoiesis, resulting in erythroblastosis, which is the presence of nucleated red blood cells in the peripheral circulation. The assay does not distinguish between micronucleated and nucleated red blood cells, and thus this causes a false-positive increase in the percentage of micronucleated NCEs (Supplementary Fig. 1a,b) .
With the high-throughput micronucleus assay, there is a positive correlation between the percentage of RETs and the percentage of micronucleated NCEs (Supplementary Fig. 1b) . The use of an anti-CD71 transferrin receptor antibody enables the researcher to quantify RETs to ensure that numbers are within normal limits (e.g., for healthy C57BL/6 mice, RETs should constitute 1-2% of the total red blood cell population; Supplementary Fig. 1c) . Furthermore, the assay relies on the distinction of blood cells by size and granularity, and therefore any changes to these parameters could result in a false-positive increase in the number of micronucleated red blood cells. As a rule of thumb, if other changes in other hematopoietic parameters are observed, such as but not limited to red blood cell distribution width, we would confirm the micronucleated cell type using microscopy. A simple method for confirming a change in micronucleated NCEs would be to perform cell counts on fresh blood smears stained with MayGrünwald-Giemsa (Fig. 1b) or on methanol-fixed blood samples costained with DAPI on slides (Fig. 1c,d ). 
Experimental design
Test and control mice should be matched by sex, age and genetic background, as all of these factors influence micronucleus induction in mice (Box 1 and Fig. 3a,b) . The assay is highly sensitive and reproducible if screening is performed with mice of the same sex that are bred on a pure genetic background (Fig. 3c) . It is possible to detect minimal changes with statistical significance using the appropriate sample number (Box 1 and Fig. 3d) . The simplest way to generate positive control animals for the assay is to expose wild-type mice to genotoxic agents, including treatment with 1 mg/kg mitomycin C (MMC) or 0.75 gray (Gy) irradiation (Box 2; Fig. 4a,b, respectively) . Alternatively, several mouse models with elevated micronucleus levels, such as the Slx4-null mouse (Fig. 4c-e) , have previously been characterized, and mice, or their blood samples, could be requested from the corresponding author of the study (see the review by Balmus and McIntyre 42 ) . Notably, the experimenter should ensure that the experiment is performed in accordance with relevant local animal research regulations and ARRIVE guidelines 43 . Heparin Prepare a 500 USP U/ml (2.35 mg/ml) solution in sterile PBS. Filter (0.22-µm filter) and divide the solution into 300-µl aliquots in 1.5-ml tubes, and store them at −20 °C for up to 1 year. Do not freeze-thaw more than three times. The solution may be stored at 4 °C for several weeks in 1.5-ml tubes, but evaporation occurs over longer periods. Fixative More than 12 h before blood collection, divide methanol into 2-ml aliquots in 15-ml conical tubes in a chemical safety cabinet and cap them tightly. It is recommended to prepare at least two tubes per blood sample from each mouse, but to process one sample and keep the second sample for technical repetition or for back-up. Place tubes in a −80 °C freezer for >12 h and <1 month. We do not recommend long-term storage of methanol aliquots in the freezer; rather, methanol should be stored in a suitable 'flammables' cupboard away from sources of ignition. ! cautIon Methanol is flammable, corrosive and toxic, and thus it should be handled in a chemical safety hood away from sources of ignition, and wear gloves, safety glasses and a laboratory coat when handling it. Bicarbonate buffer Prepare 0.9% (wt/vol) NaCl and 5.3 mM sodium bicarbonate (84 g/mol), and bring the pH to 7.5 by adding HCl. Autoclave and store the buffer at 4 °C for up to 1 year. A 10× stock solution can be prepared, autoclaved and stored at 4 °C for up to a year, but the pH must be determined for the 1× solution again when diluted for use. ! cautIon HCl is Fig. 2a ,b for profiles associated with incomplete digestion of RNA).
MaterIals

REAGENTS
Animals We obtain our mice from The Jackson Laboratory. The care and use of all mice that are used to generate data for this protocol was carried out in accordance with UK Home Office regulations, UK Animals (Scientific Procedures) Act of 2013. Our mice are maintained in a specific pathogen-free unit on a 12-h light: 12-h dark cycle with lights off at 19:30 and no twilight period. The ambient temperature is 21 ± 2 °C, and the humidity is 55 ± 10%. Mice are housed using a stocking density of 3-5 mice per cage (overall dimensions of caging: 365 × 207 × 140 mm (length × width × height), floor area 530 cm 2 ) in individually ventilated caging (Tecniplast, Sealsafe 1284L) receiving 60 air changes per hour. In addition to Aspen bedding substrate, standard environmental enrichment of two Nestlets, a cardboard fun tunnel and three wooden chew blocks are provided. Mice are given water and diet ad libitum. EQUIPMENT SETUP Flow cytometer Warm up the lasers for 30 min and prepare the instrument for high-throughput sample analysis using a 96-well plate (refer to the manufacturer's instrument setup guide). The fluorescence emitted from FITC-conjugated anti-CD71 and PI is collected through a 530/30-nm and a 610/20-nm band-pass filter after excitation by the blue 488-nm and the green 561-nm laser, respectively. Data resolution is improved and compensation is not required when the fluorochromes are excited and detected independently of each other using a 488-nm and a 561-nm laser configuration. When a single 488-nm blue laser is used in this experiment, compensation is required during data acquisition, as FITC and PI have a slight spectral overlap (please refer to the reagent supplier's technical sheet), the same excitation wavelength and the same detection light path (please refer to your instrument's technical specifications). Set the high-throughput sampler to mix each sample 2-4 times before acquiring 200,000 events per sample at a rate of 1,000-2,000 events per second. The preparation of single fluorochrome and unstained controls from surplus sample to setup the regional gates for the analysis of the erythrocyte cell population is included in the main protocol.  crItIcal step Maintain an acquisition rate of <2,500 events per second on a volumetric flow rate of 0.5-1 µl/s. A higher volumetric flow rate can result in an increased rate of false-positive events for the CD71-FITC-positive, PI-positive population (Supplementary Fig. 2a,c) .
proceDure Blood collection, fixation and storage • tIMInG ~10 min per mouse 1| Collect 50 µl of blood (e.g., two or three drops from a tail vein or retro-orbital bleed) into 300 µl of heparin solution in a 1.5-ml tube 44 . Alternatively, blood can be collected into a heparinized Vacutainer; however, it must then be transferred to the heparin solution to ensure proper single-cell dissociation of the cells before fixation. ! cautIon Blood must be obtained from mice using a technique that is approved by local regulatory bodies and/or ethics committees 44 .  crItIcal step Ensure that the blood sample is fixed within 12 h of collection to minimize the risk of sample degradation, which is one of the most common sources of false positives (supplementary Fig. 3) . ? trouBlesHootInG 2| Rapidly expel 150 µl of heparin-blood mix directly over the 2-ml aliquot of cold methanol (taken straight out of the −80 °C freezer) using a pipette, and cap the 15-ml tube. Repeat this step for the duplicate tube.  crItIcal step Do not put the pipette tip in the methanol, and do not let the blood touch the side of the tube, or aggregation may occur.  crItIcal step The temperature of the methanol must be −80 °C before fixation, as warmer methanol causes the blood to turn red-brown (supplementary Fig. 2d) , and it alters the size and granularity of the blood cells, leading to a false-positive increase in micronucleated erythrocytes (supplementary Fig. 3 ). The blood sample should remain bright red in fixative. ? trouBlesHootInG 3| Invert the sample 4-5 times to prevent aggregation, and store the tubes at −80 °C for at least 12 h before continuing. We recommend that the tubes be returned to their original polystyrene packaging, as this provides added protection should the freezer fail. We do not recommend transferring samples to a −20 °C freezer after fixation, as warmer methanol temperatures change the size and granularity of blood cells, which can result in a slight elevation of the micronucleated NCE population (supplementary Fig. 3) . ? trouBlesHootInG  pause poInt When methanol-fixed samples are stored at −80 °C, they remain stable for up to 1 year (supplementary Figs. 2e and 4) . At this stage, the 15-ml tubes of methanol-fixed samples can be placed in a sealed bag, shipped on dry ice and stored in a −80 °C freezer upon arrival at the new destination.
sample preparation • tIMInG 3-4 h for 96 samples 4| While working on ice, add 12 ml of cold (4 °C) bicarbonate buffer, and cap and invert the 15-ml tubes to mix the contents. Centrifuge the tubes at 500g for 5 min at 4 °C.  crItIcal step Samples must remain cold, especially while the cells are in undiluted methanol; if samples become warm at this stage, they may turn red-brown ( supplementary Fig. 2f) ; the size and granularity of blood cells can change and the data may be uninterpretable (supplementary Fig. 3) . 13| By using the unstained control, acquire events with logarithmic side scatter (SSC-A-log) versus linear forward scatter (FSC-A-lin) axes. The SSC-versus-FSC plot should reveal two or three overlapping populations of red blood cells with reasonably well-defined edges. Center the main population (erythrocytes) using the voltage and gain settings, and create the first gate (R1) just inside the erythrocyte population (Fig. 5a) . ? trouBlesHootInG 14| Isolate doublets by plotting FSC-W-lin versus FSC-A-lin and set gate R2 around single cells (Fig. 5b). 15| Add 2.5 µl of PI to the PI-only control tube, leave it for a few minutes and acquire the events. Adjust the voltage and gain to ensure that all events are within the axes, and draw a quadrant gate to separate the positive and negative populations. Repeat this step for the CD71-FITC-only control.
16|
Use the PI single-stain control to identify events caused by autofluorescence (supplementary Fig. 5) , and remove by setting gate R3 on the PI biexponential scale versus SSC biexponential scale axes ( Fig. 5c and supplementary Fig. 5d ).
17| On CD71-FITC-biexponential versus PI-biexponential axes, gate the four different populations (RET, Q1; MN-RET, Q2; MN-NCE, Q3; NCE, Q4; Fig. 5d ). ? trouBlesHootInG 18| Save the experiment settings on the flow cytometer.
19| Switch the flow cytometer from tube mode to multititer-well plate mode.
20|
Set the volume to 70 µl, mixes to 4 and volumetric flow rate to 0.5 or 1 µl/s (to achieve ~1,000-2,000 events per second). ? trouBlesHootInG 21| Add 1 µl of PI to each well of the plate using a multipipettor, loading 24 wells at a time. Loading more than 24 wells at a time may increase variability (supplementary Fig. 4b) . Although pipetting 1 µl is not as accurate as pipetting larger volumes, our data suggest high assay reproducibility (Box 1). We routinely use an eight-channel Biopette (1-10 µl) or an Eppendorf Multipette Plus. Mix by pipetting up and down with a multichannel pipette (20-200 µl) , and then incubate the plate for a few minutes at room temperature. ? trouBlesHootInG 22| Load the saved protocol, and then acquire and save data. ? trouBlesHootInG 23| Export the data, repeat the analysis (create gate R1 around erythrocytes, isolate doublets and set gate R2, remove autofluorescence by setting gate R3, gate the four populations) using appropriate software (e.g., FlowJo, TreeStar). ? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG For 96 samples Day 1 (Reagent Setup): prepare bicarbonate buffer (10 min), autoclave it and place it at 4 °C. Label 192 15-ml tubes (96 × 2), transfer 2 ml of methanol into each and place them at −80 °C (~2 h) . 3b) Sample degradation; heparin solution was made in water and not saline
Always fix the blood sample on the day of blood collection. The ideal profile fits the one in Figure 5a 2-4 Samples are tinged brown rather than bright red; SSC-versus-FSC plot shows reduction in FSC scattering (i.e., population shifts left, and the cell populations are less well defined (supplementary Figs. 2d,f and 3d,e) )
Samples have been fixed with warm fixative; Samples have become too warm during preparation
Always use super-chilled methanol (−80 °C) to fix blood, as warmer methanol temperatures change the size and granularity of blood cells, and this results in overlap between a nuclear red blood cells and nuclear white blood cells (SSC-versus-FSC plot). This causes an apparent elevation of the micronucleated NCE population. Correct fixation is indicated by a brightred sample color in the fixative (supplementary Fig. 2d ) and a profile that fits the one shown in Figure 5a Prepare samples on ice and centrifuge them at 4 °C If the cellular origin of the PI positivity is in question, we recommend performing fresh blood smears and staining with May-Grünwald-Giemsa (Fig. 1b) or to cyto-spinning methanol-fixed samples (e.g., from a duplicate 15-ml tube) onto slides and co-stain with DAPI (Fig. 1c,d Reticulocytosis Extreme reticulocytosis is likely to cause a falsepositive increase in the number of FITC − , PI + events (MN-NCE). Therefore, it would be preferable to score the cells for the presence of a nucleus or MN with a microscope after smearing methanol-fixed blood onto slides and co-staining with DAPI (Fig. 1c,d ) 13 Mice are of a mixed genetic background
Increase the sample number
Genotyping error Re-genotype
The flow cytometric quadrants (FITC-versus-PI plot) are defined as Q1, RET; Q2, MN-RET; Q3, MN-NCE; Q4, NCE.
